Cyclerion Therapeutics In...

NASDAQ: CYCN · Real-Time Price · USD
2.39
0.06 (2.58%)
At close: Aug 15, 2025, 3:59 PM
2.39
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Cyclerion Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-3.06M -5.26M -44.08M -51.65M
Depreciation & Amortization
n/a n/a 65K 472K
Stock-Based Compensation
625K 1.07M 6.25M 9.61M
Other Working Capital
-619K -2.92M -4M 988K
Other Non-Cash Items
-363K -12.45M 5.24M 881K
Deferred Income Tax
n/a n/a -5.24M 2.76M
Change in Working Capital
-1.54M -4.6M -2.85M 1.41M
Operating Cash Flow
-4.33M -21.25M -40.61M -36.52M
Capital Expenditures
n/a n/a n/a -7K
Cash Acquisitions
n/a n/a n/a 1.46M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 10.4M n/a 1.46M
Investing Cash Flow
n/a 10.4M n/a 1.46M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 5.02M 29K 282K
Financial Cash Flow
n/a 5.02M 29K 30.79M
Net Cash Flow
-4.34M -5.81M -40.58M -4.27M
Free Cash Flow
-4.33M -21.25M -40.61M -36.52M